We are live on ! Find out more
EYEGW

Eyegate Pharmaceuticals, Inc. Warrants
EYEGW

Delisted

EYEGW was delisted on the 5th of August, 2020.

Back to rankings

3 hedge funds and large institutions have $13K invested in Eyegate Pharmaceuticals, Inc. Warrants in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

0% more capital invested

Capital invested by funds: $13K → $13K ($0)

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AIC
1
AWM Investment Company
New York
$12K – – –
CH
2
CVI Holdings
Delaware
$1K – – –

EYEGW Hedge Fund Activity: Q2 2018 in Review

3 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Eyegate Pharmaceuticals, Inc. Warrants (EYEGW) for Q2 2018, worth a combined $13K — unchanged from a quarter earlier.

Fund positioning in EYEGW was balanced in Q2 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 3 institutional investors held Eyegate Pharmaceuticals, Inc. Warrants (EYEGW) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $13K of Eyegate Pharmaceuticals, Inc. Warrants stock for Q2 2018, unchanged quarter-over-quarter.
  • 0 funds opened new Eyegate Pharmaceuticals, Inc. Warrants positions in Q2 2018 and 0 closed out.

Based on aggregated 13F filings for Q2 2018.